Kailera Therapeutics, Inc.

NASDAQ:KLRA

Biotechnology

Healthcare
$11.79 +2.66%

+$0.51 today

Market cap
$1.53B
Beta
0.00
52W Low $18.50High $28.23

Volume 0.42M

Average 0.80M

KLRA Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How KLRA compares with its peers on the latest reported figures

KLRA Competitors Peer median
Net Margin for KLRA and competitors
Company Period LTM level YoY 3-year change
ORMPOramed Pharmaceuticals Inc.FY20253202.5% —+4599.6 pp
VTVTvTv Therapeutics Inc.LTM Mar 20266.1% +109941.4 pp—
BIOABioAge Labs, Inc.LTM Mar 2026-871.8% +4024.5 pp—
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026-3644.2% -3385.3 pp-883.7 pp
ALTAltimmune, Inc.LTM Mar 2026-253002.8% +198197.2 pp-339438.9 pp
KLRAKailera Therapeutics, Inc.FY2025— ——
VKTXViking Therapeutics, Inc.FY2025— ——
MBXMBX Biosciences, Inc. Common StockFY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding KLRA) -871.8%+56983.0 pp-883.7 pp

Competitors are the stored peer set for KLRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kailera Therapeutics, Inc.

NASDAQ:KLRA

Intrinsic Alpha fair value

Locked

Current Price

$11.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.